• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROPORT ORTHOPEDICS INC. STEM REVISION; HIP COMPONENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROPORT ORTHOPEDICS INC. STEM REVISION; HIP COMPONENT Back to Search Results
Model Number PHA00612
Medical Device Problem Code Device Dislodged or Dislocated (2923)
Health Effect - Clinical Code Insufficient Information (4580)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
This event will be updated once the investigation is complete.Trends will be evaluated.
 
Event or Problem Description
Clinical study # (b)(4).Patient # (b)(6) reported the following adverse event: hip dislocation.Dislocation was treated with close reduction.This adverse event did not end in re-revision surgery.No further information is provided due to privacy policies.
 
Additional Manufacturer Narrative
The alleged complaint could not be confirmed.Mpo was made aware of this incident through a clinical study performed using mpo implants.It is unknown when this incident occurred or how long the implants were implanted prior to the incident.These implants were not returned for investigation, nor were any pictures provided to assist with the investigation.Medical data was provided which listed implant information such as the lot numbers.These implants were manufactured in 2007 (pha00612 and pha02858), 2008 (pha03858), 2010 (pha04410), and 2011 (pha01232).Review of the design history records (dhr) for the subject manufacturing lots indicate that these implants were manufactured to specification.It cannot be concluded what level of contribution, if any, that the product had to the complaint.No further evaluations can be made without return of the product or receipt of other clinical information.The mpo hip systems package insert (150803-9) lists.Dislocation, migration and/or subluxation of prosthetic components from improper positioning, trauma, loss of fixation and/or muscle and fibrous tissue laxity; as a potential adverse effect of total hip arthroplasty.Additionally, it also states periodic, long-term follow-up is recommended to monitor the position and state of the prosthetic components, as well as the condition of the adjoining bone.Periodic post-operative xrays are recommended for close comparison with early post-op conditions to detect long term evidence of changes in position, loosening, bending, or cracking of components.Mpo will continue to monitor this issue through complaint tracking.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STEM REVISION
Common Device Name
HIP COMPONENT
Manufacturer (Section D)
MICROPORT ORTHOPEDICS INC.
5677 airline rd.
arlington TN 38002
Manufacturer Contact
rachael wise
5677 airline road
arlington, TN 38002
9018674771
MDR Report Key21323617
Report Number3010536692-2025-00032
Device Sequence Number12794248
Product Code LPH
UDI-Device IdentifierM684PHA006121
UDI-PublicM684PHA006121
Combination Product (Y/N)N
Initial Reporter CountryPL
PMA/510(K) Number
K021346
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 12/05/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Other
Device Model NumberPHA00612
Device Catalogue NumberPHA00612
Device Lot Number058479045
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/15/2025
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date02/06/2025
Supplement Report FDA Received Date12/05/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) Yes
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-